Weight loss method for people with overweight or obesity in primary care
Placebo-Controlled, Randomized Weight Loss InterventionTrial in Subjects With Overweight or Obesity in Primary Health Care
This study tests a new weight loss method called LEVA to see if it can help people with overweight or obesity in primary care lose weight and keep it off.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | Vastra Gotaland Region Government |
| Locations | 1 site (Gothenburg) |
| Trial ID | NCT04184479 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of the LEVA method by Bertz et al, which is designed to promote sustainable weight loss in individuals with overweight or obesity. The trial focuses on patients referred to primary health care centers in Västra Götalandsregionen. By assessing the method's impact beyond postpartum women, the study aims to determine its broader applicability for weight management in various patient groups. Participants will engage with digital tools as part of the intervention to facilitate their weight loss journey.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18-75 with a BMI between 27 and 35.
Not a fit: Patients who have difficulty understanding Swedish or are unwilling to use digital tools may not benefit from this study.
Why it matters
Potential benefit: If successful, this method could provide a new, effective treatment option for individuals struggling with overweight and obesity.
How similar studies have performed: While the LEVA method has been previously studied for postpartum women, its application to a broader population is relatively novel and untested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * BMI 27 ≤ 35 * age 18-75 år Exclusion Criteria: * difficulty understanding Swedish, spoken or read * does not manage/want to handle digital Tools * the remittance was addressed to Primärvårdens Dietistenhet at wrong premises and the patient should be treated elsewhere.
Where this trial is running
Gothenburg
- Västra Götalandsregionen — Gothenburg, Sweden (Recruiting)
Study contacts
- Principal investigator: Else Johansson — Västra Götalandsregionen
- Study coordinator: Else Johansson
- Email: else.hellebo.johansson@vgregion.se
- Phone: +46768871219
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.